CompletedPhase 4

Daily Chlorhexidine Care at the Exit Site in Peritoneal Dialysis Patients

89 participantsStarted 2010-05

Plain-language summary

Chlorhexidine is used in central line dressing changes and is effective in reducing line infections. It is unclear if daily chlorhexidine care at the exit site in peritoneal dialysis (PD) patients can reduce the risk of Staphylococcus aureus (SA) colonization or exit site infection.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients \> 20 years old who received PD for more than 3 months Exclusion Criteria: * a history of psychological illness or condition that interferes with caring of a wound * recent (within 1 month) exit-site infection, peritonitis, or tunnel infection * recent treatment with an antibiotic administered by any route in the last month * or known hypersensitivity to or intolerance of chlorhexidine or mupirocin

What they're measuring

exit site bacterial colonization status

Timeframe: 1 year

Trial details

NCT IDNCT02446158

SponsorE-DA Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-05

View on ClinicalTrials.gov More Peritoneal Dialysis Catheter Exit Site Infection trials